NANCY SARAH SHULMAN, M.D.
Osteopathic Medicine in Palo Alto, CA

License number
California G82023
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
3801 Miranda Ave Building Mb4 ROOM 442, Palo Alto, CA 94304
Phone
(650) 498-5000
(650) 852-1268

Professional information

Nancy S Shulman Photo 1

Dr. Nancy S Shulman, San Mateo CA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
222 W 39Th Ave, San Mateo 94403
(650) 573-2385 (Phone), (650) 289-6890 (Fax)
3801 Miranda Ave STE MB4, Palo Alto 94304
(650) 498-5000 (Phone)
San Mateo Office
222 W 39Th Ave, San Mateo 94403
(650) 573-2222 (Phone), (650) 369-3309 (Fax)
EDISON CLINIC
222 W 39Th Ave STE 1ST, San Mateo 94403
(650) 573-2385 (Phone), (650) 573-2474 (Fax)
Certifications:
Infectious Disease, 1998, Internal Medicine, 1995, Pediatrics, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
222 W 39Th Ave, San Mateo 94403
3801 Miranda Ave STE MB4, Palo Alto 94304
San Mateo Office
222 W 39Th Ave, San Mateo 94403
EDISON CLINIC
222 W 39Th Ave STE 1ST, San Mateo 94403
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University of Kansas / School of Medicine
Graduated: 1991
U Chicago-Pritzker Sch Med
Stanford University


Nancy Sarah Shulman Photo 2

Nancy Sarah Shulman, Palo Alto CA

Specialties:
Internal Medicine, Infectious Disease
Work:
Positive Care
3801 Miranda Ave, Palo Alto, CA 94304
Education:
University of Kansas(1991)


Nancy Shulman Photo 3

Prediction Of Early Virological Response In Hcv Treatment

US Patent:
2012009, Apr 19, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084216
Inventors:
Uri Lopatin - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
C12Q 1/68, G01N 33/50
US Classification:
435 611, 436 94
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.


Nancy Shulman Photo 4

Prediction Of Hcv Viral Kinetics In Interferon-Free Treatment

US Patent:
2012019, Aug 2, 2012
Filed:
Jul 29, 2011
Appl. No.:
13/194248
Inventors:
Tom Chu - Sunnyvale CA, US
Uri A. Lopatin - San Francisco CA, US
Nancy Shulman - Palo Alto CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
C12Q 1/70
US Classification:
435 5
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-free treatment.


Nancy Shulman Photo 5

Single Nucleotide Polymorphisms That Predict Hcv Treatment Outcomes

US Patent:
2012009, Apr 19, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084187
Inventors:
Uri Lopatin - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
G01N 33/50
US Classification:
436 94
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.